Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Ibuprofen products are in shortage in Canada (2 of 14 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
An anti-inflammatory (NSAID) used to relieve pain, fever and inflammation.
Products affected
2 / 14
In shortage since
May 12, 2021
Reports on file
40
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
APO-IBUPROFEN TAB 600MG
600MG · TABLET · APOTEX INC
DIN 00585114 · since Jun 23, 2026, est. end Jul 3, 2026 · Disruption of the manufacture of the drug.
Active shortage
EXTRA STRENGTH IBUPROFEN LIQUID GEL CAPSULES
400MG · CAPSULE · APOTEX INC
DIN 02376601 · since May 12, 2021, no end estimate · Disruption of the manufacture of the drug.
Discontinued
TEVA-PROFEN
600MG · TABLET · TEVA CANADA LIMITED
DIN 00629359
Resolved
APO-IBUPROFEN
400MG · TABLET · APOTEX INC
DIN 00506052 · ended Apr 4, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-IBUPROFEN TAB 600MG
600MG · TABLET · APOTEX INC
DIN 00585114 · ended Mar 28, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-IBUPROFEN
200MG · TABLET · APOTEX INC
DIN 00441643 · ended Mar 28, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-IBUPROFEN TAB 600MG
600MG · TABLET · APOTEX INC
DIN 00585114 · ended Nov 30, 2023 · Disruption of the manufacture of the drug.
Resolved
APO-IBUPROFEN TAB 600MG
600MG · TABLET · APOTEX INC
DIN 00585114 · ended Apr 20, 2023 · Disruption of the manufacture of the drug.
Resolved
APO-IBUPROFEN
400MG · TABLET · APOTEX INC
DIN 00506052 · ended Feb 8, 2023 · Disruption of the manufacture of the drug.
Resolved
APO-IBUPROFEN
200MG · TABLET · APOTEX INC
DIN 00441643 · ended May 13, 2022 · Disruption of the manufacture of the drug.
Discontinued
PMS-IBUPROFEN
600MG · TABLET · PHARMASCIENCE INC
DIN 00839264
Discontinued
PMS-IBUPROFEN
600MG · TABLET · PHARMASCIENCE INC
DIN 00839264
Showing 12 of 40 reports. All reports are on file with Health Canada.
What's happening
Ibuprofen is currently affected by 2 active shortage reports filed with Health Canada by APOTEX INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Ibuprofen is classified under “ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS” (ATC M01AE).
Recent changes
No changes recorded yet.
Common questions
What is Ibuprofen used for?
An anti-inflammatory (NSAID) used to relieve pain, fever and inflammation.
When will Ibuprofen be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Ibuprofen in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.